In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205–502
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 440 (1) , 123-132
- https://doi.org/10.1016/0006-8993(88)91164-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- In vivo labeling of dopamine receptors: Light microscopic localization at the cellular level by means of dipping autoradiography with the agonist (3H)N-n-propylnorapomorphineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptorsTrends in Pharmacological Sciences, 1986
- Pharmacological profile of the abeorphine 201–678, a potent orally active and long lasting dopamine agonistLife Sciences, 1986
- [3H]205-501, a Non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5, 6-ADTNLife Sciences, 1983
- Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypiesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Neuroleptic and dopamine receptors: Autoradiographic localization of [3H]spiperone in rat brainBrain Research, 1979
- Dopamine receptor binding in vivo: The feasibility of autoradiographic studiesLife Sciences, 1978
- In vivo binding of 3H-pimozide in mouse striatum: Effects of dopamine agonists and antagonistsLife Sciences, 1977